Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

NCT02202395 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: LTS 0.25mg
DRUG: LTS 0.5mg
DRUG: LTS 1.0mg
DRUG: Placebo

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd